share_log

WisdomTree BioRevolution Fund (BATS:WDNA) Stock Price Down 0.8%

Defense World ·  Apr 5, 2023 14:22

WisdomTree BioRevolution Fund (BATS:WDNA – Get Rating) fell 0.8% on Tuesday . The stock traded as low as $17.05 and last traded at $17.05. 403 shares changed hands during trading, The stock had previously closed at $17.19.

WisdomTree BioRevolution Fund Trading Down 0.8 %

The company has a fifty day simple moving average of $17.43 and a two-hundred day simple moving average of $17.59.

Get WisdomTree BioRevolution Fund alerts:

Institutional Trading of WisdomTree BioRevolution Fund

An institutional investor recently raised its position in WisdomTree BioRevolution Fund stock. Flow Traders U.S. LLC raised its stake in WisdomTree BioRevolution Fund (BATS:WDNA – Get Rating) by 15.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 93,700 shares of the company's stock after acquiring an additional 12,679 shares during the quarter. Flow Traders U.S. LLC's holdings in WisdomTree BioRevolution Fund were worth $1,627,000 at the end of the most recent quarter.

WisdomTree BioRevolution Fund Company Profile

(Get Rating)

The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.

Read More

  • Get a free copy of the StockNews.com research report on WisdomTree BioRevolution Fund (WDNA)
  • C3.ai Stock Plummets: Kerrisdale Capital's Latest Target
  • These Inflation-Resistant Restaurant Stocks Have Yield and Value
  • Shock and Awe. PVH Holdings Stock Surges on Earnings Blowout
  • Macy's Gets Upgrade From JP Morgan On Renewed Confidence
  • Should You Ride the Bullish Wave with Standex? Technicals Say Yes

Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment